LONDON--(BUSINESS WIRE)--Oncology drugs are seeing a sharp increase in demand as cancer rates rise worldwide and treatment becomes more advanced and readily available. Competition between oncology pharmaceutical companies is changing in response to consumer needs and market opportunities. Innovation is a major factor in this industry. Key vendors are focusing on the development of multifunctional oncology drugs that offer increased patient comfort, better treatment, and improved patient outcomes for individuals across the world.
BizVibe is one of the largest b2b networks for drug manufacturing companies in the world, with over 330,000 buyers, suppliers, and manufacturers in the global pharmaceutical industry.
Network with the Top Oncology Pharmaceutical Companies
In a recent article titled Top 10 Oncology Drugs Companies, BizVibe reveals 2017’s top 10 Oncology pharmacompanies and the best-selling drugs that they are bringing to the market.
Top 10 Oncology Drugs Companies of 2017
10. Bristol-Meyers Squibb: BMS has a wide portfolio of oncology drugs. Its top-selling oncology drugs, Erbitux and Yervoy, generated sales totaling USD 1.9 billion and USD 960 million respectively last year.
9. Eli Lilly: Of Lilly’s total USD 21 billion drug manufacturing revenue from last year, roughly USD 3.72 billion was generated from the company’s oncology segment. Sales of its top-selling oncology drug, Almita, totaled USD 2.5 billion last year.
8. AstraZeneca: Much of AstraZeneca’s revenue is generated through the sale of oncology drugs, including Zoladex, which is used to treat prostate and breast cancers. Sales of Zoladex generate roughly USD 1 billion each year. AstraZeneca generated more than USD 23 billion in revenue last year.
7. AbbVie: In 2015, AbbVie acquired Pharmalytics, an oncology firm, and with it Pharmalytics’s blood cancer treatment,ibrutinib. Global sales of ibrutinib were projected to be worth USD 1 billion in 2016.
6. Celgene: Celgene manufactures Revlimid, one of the best-selling oncology drugs in the world. It treats multiple myeloma. Sales of Revlimid total more than USD 4 billion annually.
In addition to top oncology pharma companies, BizVibe is home to more than 7 million companies. Using BizVibe’s platform, users can generate leads, short list prospects, network with businesses from around the world, and trade seamlessly. The BizVibe platform allows you to discover the highest quality leads and make meaningful connections with companies of interest, all in real-time. Claim your company profile for free and let BizVibe connect you with potential business partners. To make things as simple as possible, use the BizVibeChatbot to create new business opportunities.
About BizVibe
The single-minded focus of BizVibe’s platform is to make networking easier. Over the years, we've searched far and wide to figure out how businesses connect and enable trade. That first interaction is usually fraught with the uncertainty of finding a potential partner vs. a potential nightmare. With this in mind, we've designed a robust set of tools to help companies generate leads, short list prospects, network with businesses from around the world and trade seamlessly.
BizVibe is headquartered in Toronto and has offices in London, Bangalore, and Beijing. For more information on the BizVibe network, please contact us.
